The Medicine Maker / Issues / 2019 / Feb / In Conversation with Dr. Martin Klatt of BASF
Discovery & Development Formulation Sponsored

In Conversation with Dr. Martin Klatt of BASF

02/20/2019 0 min read

Sponsored By

Share

The Medicine Maker's James Strachan met with business leaders and specialists to discuss the latest innovations and trends in pharmaceutical manufacturing.
Here, James speaks with Dr. Martin Klatt, Director Sales Pharma Solutions Europe from BASF.

Recommended

Related Content

The Confidentiality Barrier to AI-Enabled Drug Development
Small Molecules Small Molecules Formulation
The Confidentiality Barrier to AI-Enabled Drug Development

July 27, 2026

3 min read

AI can help formulation teams better predict performance and allocate resources, but proprietary data protections remain a critical bottleneck

Why Drug Development Still Lacks Integration
Small Molecules Small Molecules Business & Trends
Why Drug Development Still Lacks Integration

July 21, 2026

4 min read

John McDermott reflects on why early drug development remains fragmented – and how integrated approaches may shorten timelines

In Vivo CAR T: A New Route to Treating Autoimmune Disease
Cell & Gene Drug Delivery Development & Clinical
In Vivo CAR T: A New Route to Treating Autoimmune Disease

July 13, 2026

6 min read

How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments

Reformulating the Future of Small Molecules
Small Molecules Drug Discovery Formulation
Reformulating the Future of Small Molecules

June 30, 2026

1 min read

A special collection of recent stories exploring oral dose innovation, API stability, nitrosamine testing, and the evolving science of small molecule medicines